Unknown

Dataset Information

0

Targeting NF-?B pathway for the therapy of diseases: mechanism and clinical study.

ABSTRACT: NF-?B pathway consists of canonical and non-canonical pathways. The canonical NF-?B is activated by various stimuli, transducing a quick but transient transcriptional activity, to regulate the expression of various proinflammatory genes and also serve as the critical mediator for inflammatory response. Meanwhile, the activation of the non-canonical NF-?B pathway occurs through a handful of TNF receptor superfamily members. Since the activation of this pathway involves protein synthesis, the kinetics of non-canonical NF-?B activation is slow but persistent, in concordance with its biological functions in the development of immune cell and lymphoid organ, immune homeostasis and immune response. The activation of the canonical and non-canonical NF-?B pathway is tightly controlled, highlighting the vital roles of ubiquitination in these pathways. Emerging studies indicate that dysregulated NF-?B activity causes inflammation-related diseases as well as cancers, and NF-?B has been long proposed as the potential target for therapy of diseases. This review attempts to summarize our current knowledge and updates on the mechanisms of NF-?B pathway regulation and the potential therapeutic application of inhibition of NF-?B signaling in cancer and inflammatory diseases.

SUBMITTER: Yu H 

PROVIDER: S-EPMC7506548 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study.

Yu Hui H   Lin Liangbin L   Zhang Zhiqiang Z   Zhang Huiyuan H   Hu Hongbo H  

Signal transduction and targeted therapy 20200921 1

NF-κB pathway consists of canonical and non-canonical pathways. The canonical NF-κB is activated by various stimuli, transducing a quick but transient transcriptional activity, to regulate the expression of various proinflammatory genes and also serve as the critical mediator for inflammatory response. Meanwhile, the activation of the non-canonical NF-κB pathway occurs through a handful of TNF receptor superfamily members. Since the activation of this pathway involves protein synthesis, the kine  ...[more]

Similar Datasets

Proteomics Eugenol modulates the NOD1- NF-κB signaling pathway via targeting NF-κB protein in triple breast cancer cells
2023-05-10 | PXD039305 | Pride
Unknown Targeting the NF-κB signaling pathway in chronic tendon disease.
| S-EPMC6534967 | biostudies-literature
Unknown MiR-210 inhibits NF-κB signaling pathway by targeting DR6 in osteoarthritis.
| S-EPMC4525484 | biostudies-other
Unknown Non-canonical NF-κB signaling pathway.
| S-EPMC3193406 | biostudies-other
Unknown NF-κB pathway controls mitochondrial dynamics.
| S-EPMC4815975 | biostudies-other
Unknown Cancer-selective targeting of the NF-κB survival pathway with GADD45β/MKK7 inhibitors.
| S-EPMC4197335 | biostudies-literature
Unknown Anti-Inflammatory Functions of Alverine via Targeting Src in the NF-κB Pathway.
| S-EPMC7225962 | biostudies-literature
Unknown Simultaneous targeting therapy for lung metastasis and breast tumor by blocking the NF-κB signaling pathway using Celastrol-loaded micelles.
| S-EPMC6058533 | biostudies-literature
Transcriptomics Targeting the NF-κB signaling pathway in Notch1-induced T cell leukemia
2006-12-02 | GSE6396 | GEO
Unknown Mechanism of dioscin ameliorating renal fibrosis through NF‑κB signaling pathway‑mediated inflammatory response.
| S-EPMC10073814 | biostudies-literature